A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease

NCT06531395 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to strategic business decision.

Conditions

Sjögrens Disease

Interventions

DRUG: Abiprubart
DRUG: Placebo

Sponsor

Kiniksa Pharmaceuticals International, plc

Collaborators

[object Object]